Document is current
Any future updates will be listed below
-
Authors
Kim, Ji-Won http://orcid.org/0000-0002-3903-3956
Brückner, Katja E.
Badenius, Celina
Hamel, Wolfgang
Schaper, Miriam
Le Van Quyen, Michel
El-Allawy-Zielke, Elisa K.
Stodieck, Stefan R. G.
Hebel, Jonas M.
Lanz, Michael
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 27 May 2021
Accepted: 22 March 2022
First Online: 13 June 2022
Declarations
:
: This study was approved by the institutional review board of the Protestant Hospital Alsterdorf, Hamburg, Germany. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: SRGS reports personal fees from UCB Pharma, GW Pharmaceuticals, Eisai Pharma and Desitin Pharma outside the submitted work. There are no competing interests to report for JWK, KEB, CB, WH, MS, MLVQ, EKE, JMH and ML.
